Newly Approved Drug Therapies (423) Clemastine fumarate syrup, Morton Grove Pharmaceuticals,

The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Drug Info

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.

Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Immunology/Infectious Diseases | Pulmonary/Respiratory Diseases

View By: Year Company Therapeutic Areas Drug Names

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Clemastine fumarate syrup

Company: Morton Grove Pharmaceuticals
Approval Status: Approved March 1998
Treatment Area: allergic rhinitis

General Information

Clemastine Fumarate Syrup 0.5 mg/5 ml, a generic version of Novartis' Tavist Syrup, has been approved for the treatment of allergic rhinitis.

Privacy |
Glossary